OPTIC NEURITIS
Clinical trials for OPTIC NEURITIS explained in plain language.
Never miss a new study
Get alerted when new OPTIC NEURITIS trials appear
Sign up with your email to follow new studies for OPTIC NEURITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a common antihistamine restore vision in optic neuritis?
Disease control Recruiting nowThis study tests whether clemastine fumarate, an old allergy medication, can help repair the protective coating around nerves in people with acute optic neuritis (inflammation of the optic nerve). About 90 participants will receive either clemastine or a placebo for 9 months. The…
Matched conditions: OPTIC NEURITIS
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 26, 2026 03:00 UTC
-
Blood filtering breakthrough? new trial aims to save sight and mobility
Disease control Recruiting nowThis study tests whether starting plasma exchange (a blood-filtering treatment) early, rather than waiting as a last resort, leads to better vision and less disability in people with severe optic neuritis (eye nerve inflammation) or transverse myelitis (spinal cord inflammation).…
Matched conditions: OPTIC NEURITIS
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 02:56 UTC
-
Can a new drug help restore vision faster after optic nerve inflammation?
Symptom relief Recruiting nowThis pilot study tests efgartigimod alfa, an experimental drug, against a placebo in 20 adults experiencing their first episode of optic neuritis (inflammation of the optic nerve). The goal is to see if the drug, given alongside standard steroid treatment, is safe and helps visio…
Matched conditions: OPTIC NEURITIS
Phase: PHASE2 • Sponsor: Anastasia Vishnevetsky, MD, MPH • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC